Moderna ( (MRNA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Moderna’s stock is experiencing downward pressure following the announcement of a 10% workforce reduction. This decision comes as sales of their COVID-19 vaccine fall short of expectations, prompting the company to cut costs. Despite these challenges, Moderna remains hopeful with three approved products and potential new developments. Analysts have maintained a Hold consensus, reflecting a mixed outlook due to the cost-cutting measures and the potential for new products.
More about Moderna
YTD Price Performance: -23.45%
Average Trading Volume: 10,831,142
Technical Sentiment Signal: Sell
Current Market Cap: $12.63B
For further insights into MRNA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.